News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
403,327 Results
Type
Article (21445)
Company Profile (145)
Press Release (381737)
Section
Business (126080)
Career Advice (972)
Deals (23767)
Drug Delivery (95)
Drug Development (58149)
Employer Resources (89)
FDA (11685)
Job Trends (9342)
News (223501)
Policy (20749)
Tag
Academia (935)
Alliances (31417)
Alzheimer's disease (765)
Approvals (11645)
Artificial intelligence (112)
Bankruptcy (221)
Best Places to Work (7026)
Breast cancer (118)
Cancer (964)
Cardiovascular disease (84)
Career advice (793)
Cell therapy (160)
Clinical research (47963)
Collaboration (367)
Compensation (138)
COVID-19 (1386)
C-suite (91)
Data (1028)
Diabetes (139)
Diagnostics (3008)
Drug pricing (99)
Earnings (51024)
Employer resources (82)
Events (58363)
Executive appointments (330)
FDA (12221)
Funding (271)
Gene therapy (123)
GLP-1 (537)
Government (2109)
Healthcare (8519)
Infectious disease (1456)
Inflammatory bowel disease (86)
Interviews (134)
IPO (10308)
Job creations (2629)
Job search strategy (713)
Layoffs (273)
Legal (4725)
Lung cancer (146)
Manufacturing (167)
Medical device (5774)
Medtech (5777)
Mergers & acquisitions (13653)
Metabolic disorders (425)
Neuroscience (1016)
NextGen: Class of 2025 (3074)
Non-profit (1157)
Northern California (1110)
Obesity (260)
Opinion (179)
Parkinson's disease (80)
Patents (110)
People (36911)
Pharmaceutical (79)
Phase I (14908)
Phase II (20641)
Phase III (16278)
Pipeline (474)
Postmarket research (1745)
Preclinical (5430)
Radiopharmaceuticals (170)
Rare diseases (202)
Real estate (3495)
Regulatory (14919)
Research institute (984)
Resumes & cover letters (153)
Southern California (1063)
Startups (2181)
United States (10354)
Vaccines (283)
Weight loss (210)
Date
Today (127)
Last 7 days (614)
Last 30 days (1429)
Last 365 days (23172)
2025 (870)
2024 (23334)
2023 (25955)
2022 (32892)
2021 (33796)
2020 (31610)
2019 (24805)
2018 (19242)
2017 (21194)
2016 (19384)
2015 (23066)
2014 (17814)
2013 (14646)
2012 (15719)
2011 (16143)
2010 (14855)
Location
Africa (445)
Asia (26740)
Australia (3654)
California (2580)
Canada (960)
China (223)
Colorado (128)
Connecticut (115)
Europe (56255)
Florida (392)
Illinois (237)
Indiana (174)
Japan (81)
Maryland (416)
Massachusetts (2057)
Michigan (80)
Minnesota (162)
New Jersey (856)
New York (793)
North Carolina (520)
Northern California (1110)
Ohio (96)
Pennsylvania (625)
South America (652)
Southern California (1063)
Texas (406)
Utah (81)
Washington State (253)
403,327 Results for "solasia pharma k k".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Lilly Drops Up to $2.5B for Scorpion’s PI3K-inhibitor Molecule
The multi-billion deal, in which Eli Lilly will acquire Scorpion Therapeutics’ STX-478 program, is a shot in the arm for PI3K treatments, which have had a mixed history over the past few years.
January 13, 2025
·
2 min read
·
Dan Samorodnitsky
Approvals
Roche Wins First-Line Breast Cancer Nod for Oral PI3K Blocker, Projects $2.3B in Peak Sales
With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K inhibitor Piqray, which last year generated $505 million in revenue.
October 11, 2024
·
2 min read
·
Tristan Manalac
BioMidwest
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma
Bridgewest Perth Pharma announced that Cyrus K. Mirsaidi is taking the worldwide helm as CEO, including its pharmaceutical supplier division, LumaCina, and its Contract Development and Manufacturing Organization division, NovaCina.
October 24, 2023
·
3 min read
Pharm Country
Glenmark Pharmaceuticals Inc., USA Issues Voluntary Nationwide Recall for Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K Due To Failed Dissolution
Glenmark Pharmaceuticals Inc. is voluntarily recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP 10 mEq K, to the consumer level.
June 25, 2024
·
13 min read
Pharm Country
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Intelligent Bio Solutions Inc. today announced the successful completion of the in-clinic portion of its pharmacokinetic (PK) study, a core component of the Company’s clinical study plan for its 510(k) pathway for regulatory approval.
June 28, 2024
·
4 min read
Press Releases
Werfen Receives US FDA 510(k) Clearance for Aptiva® Antiphospholipid Syndrome Reagents
January 13, 2025
·
2 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Pharm Country
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Intelligent Bio Solutions Inc. today announced that it is entering the next phase of its planned 510(k) submission to the FDA.
June 18, 2024
·
4 min read
Press Releases
ARS Pharmaceuticals Announces Planned Launch of neffyinSchools Program to Provide Life-Saving Needle Free Epinephrine to Eligible K-12 Schools at No Cost
December 4, 2024
·
11 min read
Press Releases
Know Labs, Inc. Announces $300K Registered Direct Offering
December 13, 2024
·
4 min read
1 of 40,333
Next